Angel Duncan


Art Therapist, Author, Speaker, PhDc, MA, MFT, ATR 

Angel C. Duncan has an extensive background in counseling psychology, art therapy and Alzheimer’s
disease clinical research and diagnostics. She oversees education and training in Medical Life Sciences
at Life Molecular Imaging, and is the Executive Arts Director for the Cognitive Dynamics Foundation.

Angel served as the Director of Education and Research Associate for the Neuropsychiatric Research Center of Southwest Florida, later serving as the Program Director and Assistant Professor for the Masters of Art in Art Therapy and Counseling program at Albertus Magnus College in New Haven, Connecticut.

She is an Adjunct Professor at the University of Tampa, and guest teaches throughout the country.

In 2019, Angel co-developed and co-coordinates Arts in Mind, an arts program for persons with early onset and early stage dementia at the Yale University Art Gallery.

Angel resides on the Board of Directors for the Cognitive Dynamics Foundation and holds council on
the Medical Advisory Board for Lorenzo’s House, a national non-profit serving families living with
Young On-set Alzheimer’s disease.

She was a contributing blogger for The Huffington Post and LinkedIn in dementia, health and wellbeing themes in life development.

Angel is currently a Peer Reviewer for the Journal of Alzheimer’s Disease and Frontiers in Psychology.
She is a recognized speaker and consultant, working with leading organizations in brain health initiatives and diagnostic biomarker imaging research across the globe.

Angel has been interviewed and featured in diverse media for her work in dementia and mental health.

She is a widely published author, some of her contributions include: The Journal of Neurology and
Neurological Disorders, The Handbook of Geriatric Neurology, Practical Neurology, Creative Arts-Based
Group Therapy with Adolescents, Art Therapy and Healthcare, Art, Angst and Trauma, The International
Journal of Lifelong Learning in Art Education and The Journal of Alzheimer’s Disease.